Supernus Pharm (SUPN) Posts Q3 Loss of 55c/Share

Supernus Pharm (NASDAQ: SUPN) reported Q3 EPS of ($0.55), $0.07 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• RBC Capital Downgrades Wizz Air Holdings (WIZZ:LN) (WZZAF) to Underperform
• JPMorgan Upgrades ArcelorMittal (MT:NA) (MT) to Neutral